Vitamin D Level in Newly Diagnosed Breast Cancer Patients
Keywords:
Breast cancer, vitamin D deficiency, grade, newly diagnosedAbstract
Background: Vitamin D insufficiency is considered most prevalent nutritional deficiency that is untreated and undiagnosed globally. This vitamin deficiency has proliferated to pandemic levels, even though it is created in the human body when exposed to sunlight. One steroid hormone that is necessary for preserving reproductive health is vitamin D.
Materials and method: This study was conducted at Azadi Hospital - Specialized Oncology Center. The study included most of the patients with breast cancer who visited the center between February 2025 and May 2025 and the control samples taken from healthy subjects. Samples from women who were taking vitamin D supplements and osteoporosis treatment were excluded. Samples were analyzed using a Cobas instrument which depended on the spectrophotometer principle.
Results: The findings showed that the vitamin D levels in three grade I, II, and III individuals who were pre-menopausal and menopausal increased in a non-significant (P > 0.05) manner.
Conclusion: Statistical analysis of the data showed that, in comparison to healthy subjects, the vitamin D levels in general in-patient breast cancer patients of all grades declined
References
Macdonald S, Oncology R, General M. Breast cancer facts & figures 2022–2024. Am Cancer Soc. 2022;10:201006001.
Hasan MM, Mohanan P, Bibi S, Babu C, Roy YJ, Mathews A, Khatri G, Papadakos SP. Radiotherapy in breast cancer. In: Breast cancer treatment: an interdisciplinary approach. Cham: Springer Nature Switzerland; 2023. p. 69-95.
Blasiak J, Pawlowska E, Chojnacki J, Szczepanska J, Fila M, Chojnacki C. Vitamin D in triple-negative and BRCA1-deficient breast cancer—implications for pathogenesis and therapy. Int J Mol Sci. 2020;21(3670):1-16.
Welsh J. Vitamin D and breast cancer: past and present. J Steroid Biochem Mol Biol. 2018;177:15-20.
Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92(2):77-98.
Torres A, Cameselle C, Otero P, Simal-Gandara J. The impact of vitamin D and its dietary supplementation in breast cancer prevention: an integrative review. Nutrients. 2024 Feb 20;16(5):573..
Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2020;106(1):14-29.
Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys. 2012;523(1):107-14.
Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A. The role of vitamin D in breast cancer risk and progression. Endocr Relat Cancer. 2022;29(2):R33-55.
Ma Y, Yu WD, Su B, Seshadri M, Luo W, Trump DL, Johnson CS. Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol. Cancer. 2013;119(3):563-74.
Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol. 2010;121(1-2):343-8.
Song ZY, et al. Blood vitamin D levels and breast cancer risk: a meta-analysis. 2019.
Estébanez N, et al. Blood vitamin D and breast cancer risk by menopausal status: a meta-analysis. 2018.
Hossain S, et al. Vitamin D and breast cancer: an observational meta-analysis. 2019.
O’Brien KM, et al. Serum 25(OH)D and risk of postmenopausal breast cancer: a 5-year follow-up study. 2017.
